APA

Liu C., Sun H., Liu C., Sheng W., Hsieh S., Lo Y., Liu W., Su T., Yang H., Hong C., Tseng T., Chen P., Chen D., Hung C. & Kao J. (20190916). Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection. : Alimentary pharmacology & therapeutics.

Chicago

Liu C-H, Sun H-Y, Liu C-J, Sheng W-H, Hsieh S-M, Lo Y-C, Liu W-C, Su T-H, Yang H-C, Hong C-M, Tseng T-C, Chen P-J, Chen D-S, Hung C-C and Kao J-H. 20190916. Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection. : Alimentary pharmacology & therapeutics.

Harvard

Liu C., Sun H., Liu C., Sheng W., Hsieh S., Lo Y., Liu W., Su T., Yang H., Hong C., Tseng T., Chen P., Chen D., Hung C. and Kao J. (20190916). Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection. : Alimentary pharmacology & therapeutics.

MLA

Liu C-H, Sun H-Y, Liu C-J, Sheng W-H, Hsieh S-M, Lo Y-C, Liu W-C, Su T-H, Yang H-C, Hong C-M, Tseng T-C, Chen P-J, Chen D-S, Hung C-C and Kao J-H. Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection. : Alimentary pharmacology & therapeutics. 20190916.